Basics Tarsus Pharmaceuticals, Inc. Common Stock IPO Date: October 12, 2020 Sector: Healthcare Industry: Biotech Market Cap: $1.76B Activated in VL: True Average Daily Range Avg Daily Range: $0.74 | 2.78% Avg Daily Range (30 D): $0.90 | 1.94% Avg Daily Range (90 D): $1.28 | 2.68% Institutional Daily Volume Avg Daily Volume: .25M Avg Daily Volume (30 D): .56M Avg Daily Volume (90 D): .51M Trade Size Avg Trade Size (Sh.): 60 Avg Trade Size (Sh.) (30 D): 49 Avg Trade Size (Sh.) (90 D): 48 Institutional Trades Total Inst.Trades: 1,137 Avg Inst. Trade: $2.68M Avg Inst. Trade (30 D): $2.7M Avg Inst. Trade (90 D): $2.86M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.64M Avg Closing Trade (30 D): $4.69M Avg Closing Trade (90 D): $4.18M Avg Closing Volume: 76.88K         News May 29, 2025 @ 9:00 PM Tarsus to Participate in Upcoming Investor Confere... Source: N/A May 5, 2025 @ 8:40 PM Elanco Animal Health Sells Xdemvy Royalties To Bla... Source: Vandana Singh Apr 24, 2025 @ 9:00 PM Tarsus to Report First Quarter 2025 Financial Resu... Source: N/A Mar 13, 2025 @ 1:49 AM Tarsus Announces Pricing of Upsized $125.0 Million... Source: N/A Mar 6, 2025 @ 10:00 PM Tarsus to Participate in Upcoming Investor Confere... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-2.72 $-.64 $-.59 Diluted EPS $-2.72 $-.64 $-.59 Revenue $ 233.67M $ 78.34M $ 66.41M Gross Profit $ $ $ Net Income / Loss $ -104.94M $ -25.12M $ -23.11M Operating Income / Loss $ -109.17M $ -26.28M $ -24.42M Cost of Revenue $ $ $ Net Cash Flow $ -15.36M $ 80.97M $ -78.83M PE Ratio